The U.S. Supreme Court ruled in a much-anticipated decision Thursday that mifepristone, one of two pharmaceuticals used in medication abortion, can remain available under current prescribing guidelines.

Donald Trump is planning to release more details in the weeks ahead about how his administration would regulate access to medication abortion, according to comments he made during a lengthy interview with Time magazine published Tuesday.

Reproductive rights, including abortion, continue to be hot topics in Ohio and in the country as a new lawsuit seeks to reverse state law related to abortion, the battle over the six-week abortion ban goes through the courts and the U.S. Supreme Court prepares to decide a case on abortion medication.

As the enormous yellow banner unfurled in front of the steps of the U.S. Supreme Court Tuesday morning, Laura Clime-Coates turned to her 9-year-old daughter and said, “Those are the names of people who agree with us.”

The future of medication abortion access in the United States went in front of the U.S. Supreme Court justices on Tuesday, where several justices appeared somewhat skeptical as anti-abortion organizations argued use of the pharmaceutical should be moved back to what was in place before 2016.

The same U.S. Supreme Court that overturned the constitutional right to an abortion will hear oral arguments Tuesday over access to mifepristone, a pharmaceutical used in both medication abortion and miscarriage care.

The U.S. Supreme Court has been inundated with dozens of organizations seeking to weigh in on the future of the abortion pill by filing “friend of the court” briefs.

The U.S. Supreme Court will hear oral arguments on March 26 in the case that could significantly curtail access to a prescription drug used for both abortions and miscarriage care.

The U.S. Supreme Court announced Wednesday it will hear oral arguments and decide whether broad access to the abortion pill can remain legal across the United States.